<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;ff=20250226214717&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;ff=20250226214717&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Thu, 27 Feb 2025 02:47:19 +0000</lastbuilddate>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Highlights From the Circulation Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009738/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 29;150(18):1469-1474. doi: 10.1161/CIRCULATIONAHA.124.072348. Epub 2024 Oct 28.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009738/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">40009738</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072348>10.1161/CIRCULATIONAHA.124.072348</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009738</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-26</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the Circulation Family of Journals</dc:title>
<dc:identifier>pmid:40009738</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072348</dc:identifier>
</item>
<item>
<title>Error in Results</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009404/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Feb 26. doi: 10.1001/jamacardio.2025.0076. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009404/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">40009404</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2025.0076>10.1001/jamacardio.2025.0076</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009404</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-26</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Error in Results</dc:title>
<dc:identifier>pmid:40009404</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2025.0076</dc:identifier>
</item>
<item>
<title>What Counts for Worsening Heart Failure Events</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009376/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Feb 26. doi: 10.1001/jamacardio.2025.0042. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009376/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">40009376</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2025.0042>10.1001/jamacardio.2025.0042</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009376</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Gregg C Fonarow</dc:creator>
<dc:creator>Adrian F Hernandez</dc:creator>
<dc:creator>James E Udelson</dc:creator>
<dc:creator>Clyde W Yancy</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>What Counts for Worsening Heart Failure Events</dc:title>
<dc:identifier>pmid:40009376</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2025.0042</dc:identifier>
</item>
<item>
<title>Balancing Concerns-AI and Moral Agency in Medicine</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009375/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Feb 26. doi: 10.1001/jamacardio.2024.5696. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009375/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">40009375</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.5696>10.1001/jamacardio.2024.5696</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009375</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Somogy Varga</dc:creator>
<dc:creator>Asbjørn Steglich-Petersen</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Balancing Concerns-AI and Moral Agency in Medicine</dc:title>
<dc:identifier>pmid:40009375</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.5696</dc:identifier>
</item>
<item>
<title>Balancing Concerns-AI and Moral Agency in Medicine-Reply</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009374/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Feb 26. doi: 10.1001/jamacardio.2024.5699. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009374/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">40009374</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.5699>10.1001/jamacardio.2024.5699</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009374</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Sarah C Hull</dc:creator>
<dc:creator>Joseph J Fins</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Balancing Concerns-AI and Moral Agency in Medicine-Reply</dc:title>
<dc:identifier>pmid:40009374</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.5699</dc:identifier>
</item>
<item>
<title>Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009358/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: Outpatient worsening HF events requiring oral diuretic intensification were common, associated with poor prognosis, and reduced by finerenone in patients with HF with mildly reduced or preserved ejection fraction.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Feb 26. doi: 10.1001/jamacardio.2025.0016. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Worsening heart failure (HF) is commonly managed in the outpatient setting with adjustments in oral diuretic therapy. The effect of the nonsteroidal mineralocorticoid receptor antagonist finerenone on outpatient worsening HF events in patients with mildly reduced or preserved ejection fraction is unknown.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To evaluate the effect of finerenone on outpatient worsening HF events requiring oral diuretic intensification among patients with HF with mildly reduced or preserved ejection fraction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This is a secondary analysis of the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure (FINEARTS-HF), a global, multicenter randomized clinical trial. Patients had HF and an ejection fraction of 40% or greater. Data analysis was conducted from September 1 to December 10, 2024.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTERVENTION: Participants were randomized 1:1 to finerenone or placebo.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: Primary outcome events (cardiovascular death, HF hospitalization, and outpatient urgent HF visit requiring intravenous diuretic therapy) were centrally adjudicated. In this prespecified analysis, outpatient oral diuretic intensification events were defined as initiations of loop or thiazide diuretic or increases in loop diuretic dosage. The risk of all-cause death following each type of worsening HF event (HF hospitalization, urgent HF visit, or outpatient oral diuretic intensification) and the effect of finerenone on outpatient oral diuretic intensification alone or as part of an extended composite outcome with primary outcome events were evaluated.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 6001 participants (mean [SD] age, 72.0 [9.6] years; 2732 [46%] female) were enrolled. First worsening HF events included 664 HF hospitalizations, 87 urgent HF visits, and 1250 oral diuretic intensifications. Rates of death were higher following worsening HF: 27.7 (95% CI, 24.3-31.5) per 100 patient-years after HF hospitalization, 13.6 (95% CI, 8.8-21.1) per 100 patient-years after urgent HF visit, and 11.6 (95% CI, 10.2-13.1) per 100 patient-years after outpatient oral diuretic intensification compared with 4.5 (95% CI, 4.2-4.9) per 100 patient-years for patients without worsening HF. Adding outpatient oral diuretic intensification to the primary outcome increased the number of patients experiencing events from 1343 to 2238. Finerenone reduced outpatient oral diuretic intensification alone (hazard ratio [HR], 0.89 [95% CI, 0.80-0.98]; P = .02) and in an extended composite outcome that further included cardiovascular death, HF hospitalization, and urgent HF visit (HR, 0.85 [95% CI, 0.78-0.92]; P &lt; .001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: Outpatient worsening HF events requiring oral diuretic intensification were common, associated with poor prognosis, and reduced by finerenone in patients with HF with mildly reduced or preserved ejection fraction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04435626.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009358/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">40009358</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2025.0016>10.1001/jamacardio.2025.0016</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009358</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Jonathan W Cunningham</dc:creator>
<dc:creator>Safia Chatur</dc:creator>
<dc:creator>Brian L Claggett</dc:creator>
<dc:creator>Muthiah Vaduganathan</dc:creator>
<dc:creator>Akshay S Desai</dc:creator>
<dc:creator>Pardeep S Jhund</dc:creator>
<dc:creator>Guillermo Llamas Esperón</dc:creator>
<dc:creator>Carolyn S P Lam</dc:creator>
<dc:creator>Naoki Sato</dc:creator>
<dc:creator>Michele Senni</dc:creator>
<dc:creator>Sanjiv Shah</dc:creator>
<dc:creator>Adriaan Voors</dc:creator>
<dc:creator>Faiez Zannad</dc:creator>
<dc:creator>Bertram Pitt</dc:creator>
<dc:creator>Shelley Zieroth</dc:creator>
<dc:creator>Meike Brinker</dc:creator>
<dc:creator>Katja Rohwedder</dc:creator>
<dc:creator>So-Young Kim</dc:creator>
<dc:creator>James Lay-Flurrie</dc:creator>
<dc:creator>Prabhakar Viswanathan</dc:creator>
<dc:creator>John J V McMurray</dc:creator>
<dc:creator>Scott D Solomon</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial</dc:title>
<dc:identifier>pmid:40009358</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2025.0016</dc:identifier>
</item>
<item>
<title>New Right Atrial Image After Coronary Revascularization Surgery</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009357/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Feb 26. doi: 10.1001/jamacardio.2024.5690. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009357/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">40009357</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.5690>10.1001/jamacardio.2024.5690</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009357</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Clara Nuevo-Gallardo</dc:creator>
<dc:creator>María Reyes González-Fernández</dc:creator>
<dc:creator>María Yuste-Domínguez</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>New Right Atrial Image After Coronary Revascularization Surgery</dc:title>
<dc:identifier>pmid:40009357</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.5690</dc:identifier>
</item>
<item>
<title>Suspected heart failure: a clinical pattern that calls for action</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39999002/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 25:ehae846. doi: 10.1093/eurheartj/ehae846. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39999002/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39999002</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae846>10.1093/eurheartj/ehae846</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39999002</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Stefan Störk</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Suspected heart failure: a clinical pattern that calls for action</dc:title>
<dc:identifier>pmid:39999002</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae846</dc:identifier>
</item>
<item>
<title>Three strikes in a row: a challenging case of carcinoid syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39998470/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 25:ehaf087. doi: 10.1093/eurheartj/ehaf087. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39998470/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39998470</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf087>10.1093/eurheartj/ehaf087</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39998470</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Giuseppe Bruschi</dc:creator>
<dc:creator>Igor Belluschi</dc:creator>
<dc:creator>Claudio F Russo</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Three strikes in a row: a challenging case of carcinoid syndrome</dc:title>
<dc:identifier>pmid:39998470</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf087</dc:identifier>
</item>
<item>
<title>Metabolic flexibility and reverse remodelling of the failing human heart</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39998427/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: CRT acutely alters the metabolic phenotype of non-ischaemic cardiomyopathy towards a more physiological picture of FA uptake which correlates with reverse remodelling. Retained metabolic flexibility may therefore be critical for subsequent reverse remodelling.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 25:ehaf033. doi: 10.1093/eurheartj/ehaf033. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Cardiac resynchronization therapy (CRT) produces long-term reverse remodelling which requires greater adenosine triphosphate delivery to the contractile machinery. Whilst the heart retains some metabolic flexibility in non-ischaemic cardiomyopathy, whether this correlates with reverse remodelling is unknown. This study investigated whether CRT acutely changes cardiac substrate uptake, and whether this translates to favourable reverse remodelling.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The effect of CRT on cardiac substrate uptake was assessed via direct coronary flow and arteriovenous measurements, with metabolomic/lipidomic analysis on infusions of insulin/glucose and intralipid. Cardiac function was assessed with left ventricular pressure-volume loops during implantation, and cardiac magnetic resonance before and 6 months following CRT, with and without biventricular pacing.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Regardless of substrate infusion, CRT acutely improved stroke work without increasing O2 uptake on both insulin/glucose (by 34%, P = .05) and intralipid (by 36%, P = .03). This was followed by increased fatty acid (FA) uptake on insulin/glucose (R = 0.89, P = .03) and increased β-hydroxybutyrate uptake (R = 0.81, P = .05) during intralipid infusion. After 6 months, there was a 48% (P &lt; .001) reduction in left ventricular end diastolic volume, beyond that achievable by acutely shortening or lengthening QRS duration. Reverse remodelling significantly correlated with increased FA uptake with CRT on insulin/glucose (R = 0.71, P = .05) driven by long and medium chain uptake, and increased ketone uptake with CRT on intralipid (R = 0.79, P = .05).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: CRT acutely alters the metabolic phenotype of non-ischaemic cardiomyopathy towards a more physiological picture of FA uptake which correlates with reverse remodelling. Retained metabolic flexibility may therefore be critical for subsequent reverse remodelling.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39998427/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39998427</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf033>10.1093/eurheartj/ehaf033</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39998427</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Peregrine G Green</dc:creator>
<dc:creator>William D Watson</dc:creator>
<dc:creator>Benjamin M Bussmann</dc:creator>
<dc:creator>Giovanni Luigi De Maria</dc:creator>
<dc:creator>Stefan Neubauer</dc:creator>
<dc:creator>Andrew J M Lewis</dc:creator>
<dc:creator>Oliver J Rider</dc:creator>
<dc:creator>Neil Herring</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Metabolic flexibility and reverse remodelling of the failing human heart</dc:title>
<dc:identifier>pmid:39998427</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf033</dc:identifier>
</item>
<item>
<title>Endothelial PPARδ Ablation Exacerbates Vascular Hyperpermeability via STAT1/CXCL10 Signaling in Acute Lung Injury</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39996324/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: These results highlighted a novel anti-inflammatory role of PPARδ in ECs by suppressing CXCL10-mediating vascular hyperpermeability. Targeting the CXCL10 signaling shows therapeutic potential against vascular injury in acute lung injury.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Feb 25. doi: 10.1161/CIRCRESAHA.124.325855. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Vascular hyperpermeability is one of the hallmarks of acute lung injury, contributing to excessive inflammation and respiratory failure. The PPARδ (peroxisome proliferator-activated receptor delta) is an anti-inflammatory transcription factor, although its role in endothelial barrier function remains unclear. Here, we studied the essential role of PPARδ in maintaining vascular endothelial barrier integrity during lung inflammation and investigated the underlying mechanisms.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Endothelial cell (EC)-selective PPARδ knockout mice (Ppard<sup>EC-KO</sup>) and littermate control mice (Ppard<sup>EC-WT</sup>) received lipopolysaccharide injection to induce acute lung injury. Lung inflammation, pulmonary vascular leakage, and mouse mortality were monitored. Single-cell RNA sequencing was performed on sorted mouse lung ECs.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Ppard<sup>EC-KO</sup> mice exhibited aggravated lung inflammation, characterized by increased leukocyte infiltration, elevated production of proinflammatory cytokines, and higher mortality rates. The enhanced inflammatory responses were associated with increased protein leakage, interstitial edema, and impaired endothelial barrier structure, leading to vascular hyperpermeability in Ppard<sup>EC-KO</sup> mice. Mechanistically, with single-cell RNA sequencing, we identified the emergence of an interferon-activated capillary EC population marked by CXCL10 (C-X-C motif chemokine 10) expression following lipopolysaccharide challenge. PPARδ silencing significantly increased CXCL10 expression in ECs through activating STAT1. Notably, CXCL10 treatment induced degradation of tight junction proteins ZO-1 (zonula occluden-1) and claudin-5 through the ubiquitin-proteasome system, disrupting membrane junction continuity in ECs. Administration of anti-CXCL10 antibody or CXCL10 receptor antagonist AMG487 suppressed both lipopolysaccharide-induced lung inflammation and vascular leakage in Ppard<sup>EC-KO</sup> mice.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: These results highlighted a novel anti-inflammatory role of PPARδ in ECs by suppressing CXCL10-mediating vascular hyperpermeability. Targeting the CXCL10 signaling shows therapeutic potential against vascular injury in acute lung injury.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39996324/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39996324</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325855>10.1161/CIRCRESAHA.124.325855</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39996324</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Huiling Hong</dc:creator>
<dc:creator>Yalan Wu</dc:creator>
<dc:creator>Yangxian Li</dc:creator>
<dc:creator>Yumeng Han</dc:creator>
<dc:creator>Xiaoyun Cao</dc:creator>
<dc:creator>Vivian Wei Yan Wu</dc:creator>
<dc:creator>Thomas Ting Hei Chan</dc:creator>
<dc:creator>Jingying Zhou</dc:creator>
<dc:creator>Qin Cao</dc:creator>
<dc:creator>Kathy O Lui</dc:creator>
<dc:creator>Chun-Kwok Wong</dc:creator>
<dc:creator>Zhiyu Dai</dc:creator>
<dc:creator>Xiao Yu Tian</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Endothelial PPARδ Ablation Exacerbates Vascular Hyperpermeability via STAT1/CXCL10 Signaling in Acute Lung Injury</dc:title>
<dc:identifier>pmid:39996324</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325855</dc:identifier>
</item>
<item>
<title>ASH2L Deficiency in Smooth Muscle Drives Pulmonary Vascular Remodeling</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39996311/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: This study demonstrated that ASH2L deficiency causatively affects SMC proliferation and lung vascular remodeling that is partially mediated through KLF5-dependent NOTCH3 transcription. Activating ASH2L or targeting KLF5 might represent potential therapeutic strategies for PH.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Feb 25. doi: 10.1161/CIRCRESAHA.124.325539. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Histone H3 lysine 4 methylation is one of the most abundant epigenetic modifications, which has been recently linked to vascular remodeling in pulmonary hypertension (PH). SET1/MLL methyltransferase complexes comprise the main enzymes responsible for methylating H3 lysine 4, yet their roles in vascular remodeling and PH are not fully understood. We aim to assess the contribution of ASH2L, a core SET1/MLL family member, to the pathogenesis of PH.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Human pulmonary artery specimens and primary vascular cells, smooth muscle cell (SMC)-specific ASH2L-deficient mice, rats with SMC-specific ASH2L overexpression, mass spectrometry, immunoprecipitation, and chromatin immunoprecipitation were used to define the role of ASH2L in PH.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Analysis of bulk RNA-sequencing data sets from human lung vessels identified ASH2L as the only differentially expressed SET1/MLL family member in PH compared with healthy controls. Decreased ASH2L expression in human pulmonary arteries correlated with the clinical severity of PH, which contrasted with elevated H3 lysine 4 methylation and was primarily localized to SMCs. Depletion of ASH2L promoted whereas its restoration ameliorated SMC proliferation and vascular remodeling in PH. Mechanistically, we revealed that ASH2L functioned independently of the canonical H3 lysine 4 trimethylation-based transcriptional activation, while it formed a protein complex with KLF5 and FBXW7, thereby accelerating the ubiquitin-proteasomal degradation of KLF5. NOTCH3 was discovered as a new downstream target of KLF5, and the loss of ASH2L promoted the recruitment of KLF5 to the NOTCH3 promoter, thus enhancing NOTCH3 expression. Pharmacological blockage of KLF5 attenuated PH in chronic hypoxia-exposed SMC-specific ASH2L-deficient mice and sugen/hypoxia-challenged rats.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This study demonstrated that ASH2L deficiency causatively affects SMC proliferation and lung vascular remodeling that is partially mediated through KLF5-dependent NOTCH3 transcription. Activating ASH2L or targeting KLF5 might represent potential therapeutic strategies for PH.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39996311/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39996311</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325539>10.1161/CIRCRESAHA.124.325539</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39996311</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Jing Zhang</dc:creator>
<dc:creator>Xia Gu</dc:creator>
<dc:creator>Tian-Le Cheng</dc:creator>
<dc:creator>Yong-Jia Qi</dc:creator>
<dc:creator>Dao-Yan Liu</dc:creator>
<dc:creator>Na Wu</dc:creator>
<dc:creator>Da-Peng Wang</dc:creator>
<dc:creator>Yu Huang</dc:creator>
<dc:creator>Zhi-Ming Zhu</dc:creator>
<dc:creator>Ye Fan</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>ASH2L Deficiency in Smooth Muscle Drives Pulmonary Vascular Remodeling</dc:title>
<dc:identifier>pmid:39996311</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325539</dc:identifier>
</item>
<item>
<title>The year in cardiovascular medicine 2024: the top 10 papers in ischaemic heart disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39995250/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 25:ehaf078. doi: 10.1093/eurheartj/ehaf078. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39995250/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39995250</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf078>10.1093/eurheartj/ehaf078</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39995250</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Diana A Gorog</dc:creator>
<dc:creator>Ranil de Silva</dc:creator>
<dc:creator>William E Boden</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The year in cardiovascular medicine 2024: the top 10 papers in ischaemic heart disease</dc:title>
<dc:identifier>pmid:39995250</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf078</dc:identifier>
</item>
<item>
<title>Autophagy is required for the therapeutic effects of the NAD+ precursor nicotinamide in obesity-related heart failure with preserved ejection fraction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39995248/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 25:ehaf062. doi: 10.1093/eurheartj/ehaf062. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39995248/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39995248</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf062>10.1093/eurheartj/ehaf062</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39995248</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Mahmoud Abdellatif</dc:creator>
<dc:creator>Francisco Vasques-Nóvoa</dc:creator>
<dc:creator>Viktoria Trummer-Herbst</dc:creator>
<dc:creator>Sylvère Durand</dc:creator>
<dc:creator>Franziska Koser</dc:creator>
<dc:creator>Moydul Islam</dc:creator>
<dc:creator>Jihoon Nah</dc:creator>
<dc:creator>Eun-Ah Sung</dc:creator>
<dc:creator>Ruli Feng</dc:creator>
<dc:creator>Fanny Aprahamian</dc:creator>
<dc:creator>Andreas Prokesch</dc:creator>
<dc:creator>Pablo Zardoya-Laguardia</dc:creator>
<dc:creator>Junichi Sadoshima</dc:creator>
<dc:creator>Abhinav Diwan</dc:creator>
<dc:creator>Wolfgang A Linke</dc:creator>
<dc:creator>João Pedro Ferreira</dc:creator>
<dc:creator>Guido Kroemer</dc:creator>
<dc:creator>Simon Sedej</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Autophagy is required for the therapeutic effects of the NAD+ precursor nicotinamide in obesity-related heart failure with preserved ejection fraction</dc:title>
<dc:identifier>pmid:39995248</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf062</dc:identifier>
</item>
<item>
<title>Digital Twins: The Future for Ventricular Tachycardia Ablation?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993042/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):534-536. doi: 10.1161/CIRCULATIONAHA.124.072299. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993042/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39993042</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072299>10.1161/CIRCULATIONAHA.124.072299</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993042</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Dingxin Qin</dc:creator>
<dc:creator>Jagmeet P Singh</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Digital Twins: The Future for Ventricular Tachycardia Ablation?</dc:title>
<dc:identifier>pmid:39993042</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072299</dc:identifier>
</item>
<item>
<title>Correction to: Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993041/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):e677-e679. doi: 10.1161/CIR.0000000000001313. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993041/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39993041</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001313>10.1161/CIR.0000000000001313</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993041</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:39993041</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001313</dc:identifier>
</item>
<item>
<title>CXCL12 Derived From ACKR1&lt;sup>;+&lt;/sup>; Intraplaque Neovessels Mediates CD8&lt;sup>;+&lt;/sup>; T Cell Recruitment in Human Atherosclerosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993040/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):581-584. doi: 10.1161/CIRCULATIONAHA.124.072560. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993040/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39993040</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072560>10.1161/CIRCULATIONAHA.124.072560</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993040</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Laura Parma</dc:creator>
<dc:creator>Nadja Sachs</dc:creator>
<dc:creator>Nikola Sobczak</dc:creator>
<dc:creator>Zhaolong Li</dc:creator>
<dc:creator>Kevin Merchant</dc:creator>
<dc:creator>Jessica Pauli</dc:creator>
<dc:creator>Marie A C Depuydt</dc:creator>
<dc:creator>Anouk Wezel</dc:creator>
<dc:creator>Harm J Smeets</dc:creator>
<dc:creator>Ilze Bot</dc:creator>
<dc:creator>Bram Slütter</dc:creator>
<dc:creator>Lars Maegdefessel</dc:creator>
<dc:creator>Christian Weber</dc:creator>
<dc:creator>Johan Duchêne</dc:creator>
<dc:creator>Remco T A Megens</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>CXCL12 Derived From ACKR1&lt;sup>;+&lt;/sup>; Intraplaque Neovessels Mediates CD8&lt;sup>;+&lt;/sup>; T Cell Recruitment in Human Atherosclerosis</dc:title>
<dc:identifier>pmid:39993040</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072560</dc:identifier>
</item>
<item>
<title>New Stroke Awareness Campaign Focuses on Hispanic and Latino People: Culturally Relevant and Spanish-Language Resources Aim to Improve Health Knowledge and Equity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993039/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):566-567. doi: 10.1161/CIRCULATIONAHA.124.073068. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993039/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39993039</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.073068>10.1161/CIRCULATIONAHA.124.073068</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993039</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Bridget M Kuehn</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>New Stroke Awareness Campaign Focuses on Hispanic and Latino People: Culturally Relevant and Spanish-Language Resources Aim to Improve Health Knowledge and Equity</dc:title>
<dc:identifier>pmid:39993039</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.073068</dc:identifier>
</item>
<item>
<title>New Definition of Elevated Blood Pressure in the 2024 ESC Guidelines: Increased Prevalence, Uncertain Evidence</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993038/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):518-520. doi: 10.1161/CIRCULATIONAHA.124.072696. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993038/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39993038</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072696>10.1161/CIRCULATIONAHA.124.072696</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993038</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Emmanuelle Vidal-Petiot</dc:creator>
<dc:creator>Sofiane Kab</dc:creator>
<dc:creator>Philippe Gabriel Steg</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>New Definition of Elevated Blood Pressure in the 2024 ESC Guidelines: Increased Prevalence, Uncertain Evidence</dc:title>
<dc:identifier>pmid:39993038</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072696</dc:identifier>
</item>
<item>
<title>Malignant ST-Segment-Elevation in a Young Man With Syncope: Important Clues Hidden in Diagnostic Traps</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993037/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):574-577. doi: 10.1161/CIRCULATIONAHA.124.073499. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993037/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39993037</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.073499>10.1161/CIRCULATIONAHA.124.073499</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993037</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Xi Huang</dc:creator>
<dc:creator>Yubin Zhang</dc:creator>
<dc:creator>Ren Yan</dc:creator>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Malignant ST-Segment-Elevation in a Young Man With Syncope: Important Clues Hidden in Diagnostic Traps</dc:title>
<dc:identifier>pmid:39993037</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.073499</dc:identifier>
</item>
<item>
<title>Correction to: Abstract 4139285: Awareness of Myocardial Infarction and Stroke Symptoms Among Asian American Adults: Insights from the National Health Interview Survey 2014 and 2017</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39993036/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250226214717&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 25;151(8):e681. doi: 10.1161/CIR.0000000000001312. Epub 2025 Feb 24.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39993036/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250226214717&v=2.18.0.post9+e462414">39993036</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001312>10.1161/CIR.0000000000001312</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39993036</guid>
<pubDate>Mon, 24 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-24</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Abstract 4139285: Awareness of Myocardial Infarction and Stroke Symptoms Among Asian American Adults: Insights from the National Health Interview Survey 2014 and 2017</dc:title>
<dc:identifier>pmid:39993036</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001312</dc:identifier>
</item>





























</channel>
</rss>